Onyx Biotec Limited
Onyx Biotech Ltd manufactures and sells Sterile Water for Injections, Dry Powder Injections and Dry Syrup for India and overseas, through a B2B business model
What Onyx files
- Others28
- Board Meeting9
- Updates9
- Important5
- Insider Trade5
- Results2
Onyx Biotec's promoters, Sanjay Jain and Fateh Pal Singh, have sold 10 lakh and 13.4 lakh equity shares, totaling 23.4 lakh shares (12.91% of equity). This move signifies a notable shift in promoter stake.
Onyx Biotec: Promoter Fateh Pal Singh sold 1,24,000 equity shares for ₹4.39 Cr via an on-market transaction.
Onyx Biotec's promoters declared they held no encumbrance on their shares for the financial year ended March 31, 2026. This annual confirmation signals stable promoter shareholding, crucial for investor confidence.
Onyx Biotec's dry injection line secured approval to export to DRC Congo. This boosts international presence, enabling new exports and supporting the company's growth strategy in African pharmaceutical markets.
Onyx Biotec announced it is not subject to certain corporate governance requirements. Being listed on the NSE EMERGE exchange, the company is exempt from specific oversight provisions.